About Starfish Ventures
Starfish Ventures is a company based in Melbourne (Australia). Stage-agnostic sector-agnostic VC firm investing in Australia, New Zealand and the US. It operates on a B2B model.
Company details
Venture capital is provided by Starfish Ventures in a stage-agnostic and sector-agnostic approach. Sectors including FinTech, Mobile, CleanTech, and Biopharma are covered. Investments typically range from 1 million to 5 million and are directed toward companies in Australia, New Zealand, and the United States. Notable commitments have been placed in Ausra, ZoomSystems, Protagonist Therapeutics, and ICIX. The firm is based in Melbourne, Australia.
- Headquarters Melbourne, Australia
- Website starfishvc.com
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Starfish Ventures
Complete news archive for Starfish Ventures
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Starfish Ventures
Starfish Ventures is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
Venture capital is provided by Starfish Ventures in a stage-agnostic and sector-agnostic approach. Sectors including FinTech, Mobile, CleanTech, and Biopharma are covered. Investments typically range from 1 million to 5 million and are directed toward companies in Australia, New Zealand, and the United States. Notable commitments have been placed in Ausra, ZoomSystems, Protagonist Therapeutics, and ICIX. The firm is based in Melbourne, Australia.